Neutropenia Biologic Drug Treatment Market, Global Outlook and Forecast 2023-2028

Report ID: 1134820 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Neutropenia Biologic Drug Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Neutropenia Biologic Drug Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Neutropenia Biologic Drug Treatment Overall Market Size
    2.1 Global Neutropenia Biologic Drug Treatment Market Size: 2021 VS 2028
    2.2 Global Neutropenia Biologic Drug Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Neutropenia Biologic Drug Treatment Players in Global Market
    3.2 Top Global Neutropenia Biologic Drug Treatment Companies Ranked by Revenue
    3.3 Global Neutropenia Biologic Drug Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Neutropenia Biologic Drug Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Neutropenia Biologic Drug Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Neutropenia Biologic Drug Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Neutropenia Biologic Drug Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Neutropenia Biologic Drug Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Neutropenia Biologic Drug Treatment Market Size Markets, 2021 & 2028
        4.1.2 Filgrastim
        4.1.3 Pegfilgrastim
        4.1.4 Lenograstim
        4.1.5 Lipegfilgrastim
        4.1.6 Sargramostim
    4.2 By Type - Global Neutropenia Biologic Drug Treatment Revenue & Forecasts
        4.2.1 By Type - Global Neutropenia Biologic Drug Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Neutropenia Biologic Drug Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Neutropenia Biologic Drug Treatment Market Size, 2021 & 2028
        5.1.2 Retail Pharmacies
        5.1.3 Hospital Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Neutropenia Biologic Drug Treatment Revenue & Forecasts
        5.2.1 By Application - Global Neutropenia Biologic Drug Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Neutropenia Biologic Drug Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Neutropenia Biologic Drug Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Neutropenia Biologic Drug Treatment Revenue & Forecasts
        6.2.1 By Region - Global Neutropenia Biologic Drug Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Neutropenia Biologic Drug Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Neutropenia Biologic Drug Treatment Revenue, 2017-2028
        6.3.2 US Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.3.3 Canada Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.3.4 Mexico Neutropenia Biologic Drug Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Neutropenia Biologic Drug Treatment Revenue, 2017-2028
        6.4.2 Germany Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.4.3 France Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.4.4 U.K. Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.4.5 Italy Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.4.6 Russia Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.4.8 Benelux Neutropenia Biologic Drug Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Neutropenia Biologic Drug Treatment Revenue, 2017-2028
        6.5.2 China Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.5.3 Japan Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.5.4 South Korea Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.5.6 India Neutropenia Biologic Drug Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Neutropenia Biologic Drug Treatment Revenue, 2017-2028
        6.6.2 Brazil Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.6.3 Argentina Neutropenia Biologic Drug Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Neutropenia Biologic Drug Treatment Revenue, 2017-2028
        6.7.2 Turkey Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.7.3 Israel Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Neutropenia Biologic Drug Treatment Market Size, 2017-2028
        6.7.5 UAE Neutropenia Biologic Drug Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Teva Pharmaceutical
        7.1.1 Teva Pharmaceutical Corporate Summary
        7.1.2 Teva Pharmaceutical Business Overview
        7.1.3 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Major Product Offerings
        7.1.4 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.1.5 Teva Pharmaceutical Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Neutropenia Biologic Drug Treatment Major Product Offerings
        7.2.4 Amgen Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 Sanofi
        7.3.1 Sanofi Corporate Summary
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Neutropenia Biologic Drug Treatment Major Product Offerings
        7.3.4 Sanofi Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.3.5 Sanofi Key News
    7.4 Mylan(Fulphila)
        7.4.1 Mylan(Fulphila) Corporate Summary
        7.4.2 Mylan(Fulphila) Business Overview
        7.4.3 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Major Product Offerings
        7.4.4 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.4.5 Mylan(Fulphila) Key News
    7.5 Kyowa Kirin
        7.5.1 Kyowa Kirin Corporate Summary
        7.5.2 Kyowa Kirin Business Overview
        7.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Major Product Offerings
        7.5.4 Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.5.5 Kyowa Kirin Key News
    7.6 Novartis
        7.6.1 Novartis Corporate Summary
        7.6.2 Novartis Business Overview
        7.6.3 Novartis Neutropenia Biologic Drug Treatment Major Product Offerings
        7.6.4 Novartis Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.6.5 Novartis Key News
    7.7 Spectrum Pharmaceuticals
        7.7.1 Spectrum Pharmaceuticals Corporate Summary
        7.7.2 Spectrum Pharmaceuticals Business Overview
        7.7.3 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Major Product Offerings
        7.7.4 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.7.5 Spectrum Pharmaceuticals Key News
    7.8 Pfizer
        7.8.1 Pfizer Corporate Summary
        7.8.2 Pfizer Business Overview
        7.8.3 Pfizer Neutropenia Biologic Drug Treatment Major Product Offerings
        7.8.4 Pfizer Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.8.5 Pfizer Key News
    7.9 Baxter International
        7.9.1 Baxter International Corporate Summary
        7.9.2 Baxter International Business Overview
        7.9.3 Baxter International Neutropenia Biologic Drug Treatment Major Product Offerings
        7.9.4 Baxter International Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.9.5 Baxter International Key News
    7.10 Partner Therapeutics(Leukine)
        7.10.1 Partner Therapeutics(Leukine) Corporate Summary
        7.10.2 Partner Therapeutics(Leukine) Business Overview
        7.10.3 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Major Product Offerings
        7.10.4 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.10.5 Partner Therapeutics(Leukine) Key News
    7.11 BeyondSpring Pharmaceuticals
        7.11.1 BeyondSpring Pharmaceuticals Corporate Summary
        7.11.2 BeyondSpring Pharmaceuticals Business Overview
        7.11.3 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Major Product Offerings
        7.11.4 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.11.5 BeyondSpring Pharmaceuticals Key News
    7.12 Cellerant Therapeutics
        7.12.1 Cellerant Therapeutics Corporate Summary
        7.12.2 Cellerant Therapeutics Business Overview
        7.12.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Major Product Offerings
        7.12.4 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.12.5 Cellerant Therapeutics Key News
    7.13 Enzychem Lifesciences Corporation
        7.13.1 Enzychem Lifesciences Corporation Corporate Summary
        7.13.2 Enzychem Lifesciences Corporation Business Overview
        7.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Major Product Offerings
        7.13.4 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.13.5 Enzychem Lifesciences Corporation Key News
    7.14 Myelo Therapeutics
        7.14.1 Myelo Therapeutics Corporate Summary
        7.14.2 Myelo Therapeutics Business Overview
        7.14.3 Myelo Therapeutics Neutropenia Biologic Drug Treatment Major Product Offerings
        7.14.4 Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.14.5 Myelo Therapeutics Key News
    7.15 Generon
        7.15.1 Generon Corporate Summary
        7.15.2 Generon Business Overview
        7.15.3 Generon Neutropenia Biologic Drug Treatment Major Product Offerings
        7.15.4 Generon Neutropenia Biologic Drug Treatment Revenue in Global Market (2017-2022)
        7.15.5 Generon Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Neutropenia Biologic Drug Treatment Market Opportunities & Trends in Global Market
    Table 2. Neutropenia Biologic Drug Treatment Market Drivers in Global Market
    Table 3. Neutropenia Biologic Drug Treatment Market Restraints in Global Market
    Table 4. Key Players of Neutropenia Biologic Drug Treatment in Global Market
    Table 5. Top Neutropenia Biologic Drug Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Neutropenia Biologic Drug Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Neutropenia Biologic Drug Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Neutropenia Biologic Drug Treatment Product Type
    Table 9. List of Global Tier 1 Neutropenia Biologic Drug Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Neutropenia Biologic Drug Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Neutropenia Biologic Drug Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Neutropenia Biologic Drug Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Neutropenia Biologic Drug Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Neutropenia Biologic Drug Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Neutropenia Biologic Drug Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Neutropenia Biologic Drug Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Teva Pharmaceutical Corporate Summary
    Table 31. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Offerings
    Table 32. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Neutropenia Biologic Drug Treatment Product Offerings
    Table 35. Amgen Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Sanofi Corporate Summary
    Table 37. Sanofi Neutropenia Biologic Drug Treatment Product Offerings
    Table 38. Sanofi Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Mylan(Fulphila) Corporate Summary
    Table 40. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Offerings
    Table 41. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Kyowa Kirin Corporate Summary
    Table 43. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Offerings
    Table 44. Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Novartis Corporate Summary
    Table 46. Novartis Neutropenia Biologic Drug Treatment Product Offerings
    Table 47. Novartis Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Spectrum Pharmaceuticals Corporate Summary
    Table 49. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offerings
    Table 50. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Pfizer Corporate Summary
    Table 52. Pfizer Neutropenia Biologic Drug Treatment Product Offerings
    Table 53. Pfizer Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Baxter International Corporate Summary
    Table 55. Baxter International Neutropenia Biologic Drug Treatment Product Offerings
    Table 56. Baxter International Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Partner Therapeutics(Leukine) Corporate Summary
    Table 58. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Offerings
    Table 59. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 60. BeyondSpring Pharmaceuticals Corporate Summary
    Table 61. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Offerings
    Table 62. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 63. Cellerant Therapeutics Corporate Summary
    Table 64. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Offerings
    Table 65. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 66. Enzychem Lifesciences Corporation Corporate Summary
    Table 67. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Offerings
    Table 68. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 69. Myelo Therapeutics Corporate Summary
    Table 70. Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Offerings
    Table 71. Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
    Table 72. Generon Corporate Summary
    Table 73. Generon Neutropenia Biologic Drug Treatment Product Offerings
    Table 74. Generon Neutropenia Biologic Drug Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Neutropenia Biologic Drug Treatment Segment by Type in 2021
    Figure 2. Neutropenia Biologic Drug Treatment Segment by Application in 2021
    Figure 3. Global Neutropenia Biologic Drug Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Neutropenia Biologic Drug Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Neutropenia Biologic Drug Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Neutropenia Biologic Drug Treatment Revenue in 2021
    Figure 8. By Type - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 12. US Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 24. China Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Neutropenia Biologic Drug Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Sanofi Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Kyowa Kirin Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Novartis Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Pfizer Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Baxter International Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Myelo Therapeutics Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Generon Neutropenia Biologic Drug Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
101
Frequently Asked Questions
Neutropenia Biologic Drug Treatment Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neutropenia Biologic Drug Treatment Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neutropenia Biologic Drug Treatment Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports